Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

NCT03225365 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

BIOLOGICAL: Blood and biopsy sampling

Sponsor

Hospices Civils de Lyon